Research On Financial Risk Early Warning Of KH Enterprise

In the era of economic globalization,various industries have achieved vigorous development and made significant contributions to China’s economic upgrading.At the same time,various industries are also facing varying degrees of risks in production and operation.Among them,with the deepening of the reform of the medical and health system,the National Medical Security Administration and the Drug Administration have continuously strengthened their efforts to promote medical reform.The complex and diverse policy environment and the continuous and repeated global epidemic have made the pharmaceutical industry closely related to life face unprecedented opportunities and challenges in the public health system,supply chain system,and consumer market.These issues have received widespread attention from the academic and practical circles,and the "three high" characteristics of high investment,high income,and high risk in the pharmaceutical industry have also led to increasing financial risks in the industry.Therefore,the above issues have strong research value at present.This article explores from the perspective of enterprise financial risk early warning.Taking KH enterprises as an example,conducting systematic analysis and research from a point to surface perspective not only helps the pharmaceutical industry establish a sound financial risk early warning system to control financial risks,but also guides enterprises to better develop in the future to meet the new sunrise of the industry by giving feasible suggestions.This article takes KH large pharmaceutical enterprises as the research object,and conducts in-depth research on financial risk early warning of pharmaceutical enterprises through case analysis,literature review,qualitative and quantitative methods,combined with risk management theory,economic early warning theory,internal control theory,and economic cycle fluctuation theory.Firstly,by sorting out a large number of relevant domestic and foreign literature,selecting reasonable indicator evaluation methods to help KH enterprises establish a financial risk early warning system;Secondly,analyze the necessity of establishing an early warning system through the overview of KH enterprises and the identification of financial risks;Thirdly,based on the preliminary selection of indicators for the financial risk early warning system,entropy method and correlation analysis are used to screen early warning indicators and re assign weights.Then,based on the improved efficiency coefficient method,the financial early warning scores of the enterprise from 2017 to 2022 are calculated,so as to evaluate the early warning situations faced by the enterprise;Finally,based on the early warning scores of four levels of investment risk,operational risk,financing risk,and income distribution risk of KH Enterprise,summarize and analyze the financial risks that may occur in the enterprise,and propose countermeasures and early warning system safeguards for the enterprise’s financial risks,thereby helping the enterprise to reduce the impact of financial risks in production and operation to a certain extent,ensuring the healthy and stable development of the enterprise.The research in this article has enriched relevant literature research on financial risk early warning research in the pharmaceutical industry against the backdrop of the promotion of the new medical reform policy and repeated epidemics.The proposed response measures fully integrate the industry’s macro environment and the real situation of enterprises,providing ideas for the pharmaceutical industry to better respond to opportunities and challenges,with certain reference value and significance.